The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


Time/Date Code Headline Source Impact
16:11 16-Nov-2015 SNG Adoption of FRS 101 - Reduced Disclosure Framework RNS -0.29% Down
15:08 13-Nov-2015 SNG Holding(s) in Company RNS +1.27% Up
11:41 13-Nov-2015 SNG Holding(s) in Company RNS +1.27% Up
07:00 13-Nov-2015 SNG Holding(s) in Company RNS +1.27% Up
07:00 12-Nov-2015 SNG Directors' Share Purchase RNS +3.24% Up
07:00 28-Oct-2015 SNG Grant of options RNS -1.72% Down
07:00 16-Sep-2015 SNG Interim Results RNS -1.95% Down
07:00 21-Aug-2015 SNG Notice of Interim Results RNS -3.34% Down
07:00 05-Aug-2015 SNG Synairgen announces research collaboration RNS +8.56% Up
07:00 22-Jul-2015 SNG AstraZeneca commences Phase II Trial RNS -3.77% Down
13:41 22-Jun-2015 SNG Result of AGM RNS +1.32% Up
09:37 02-Jun-2015 SNG Holding(s) in Company RNS +4.14% Up
11:04 15-May-2015 SNG Notice of AGM RNS +1.40% Up
17:03 22-Apr-2015 SNG Posting of Annual Report and Accounts RNS +5.45% Up
12:55 05-Mar-2015 SNG Richard Griffiths increases stake to 6.1 percent RNS +29.98% Up
07:00 03-Mar-2015 SNG Preliminary Results RNS +21.09% Up
12:44 12-Feb-2015 SNG Holding(s) in Company RNS -5.57% Down

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.


Company Information
Updated Monthly
Company address Mailpoint 810, Level F, South Block, Southampton General Hospital, Southampton, SO16 6YD, United Kingdom
Company website
Market cap(in millions)* £ 22.56
Listing/Admission to trading 26 Oct 2004
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment AIMI
MiFID Status MTF
Exchange market size 7,500
ISIN number GB00B0381Z20

SYNAIRGEN share - news analysis